NFJ Investment Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-76,785
Closed -$5.26M – 287
2024
Q4
$5.26M Sell
76,785
-573
-0.7% -$39.9K 0.17% 137
2024
Q3
$5.56M Sell
77,358
-2,947
-4% -$208K 0.16% 138
2024
Q2
$5.57M Sell
80,305
-589
-0.7% -$43K 0.17% 129
2024
Q1
$6.48M Buy
+80,894
New +$7.21M 0.18% 121
2023
Q3
– Sell
-1,296
Closed -$176K – 222
2023
Q2
$176K Sell
1,296
-39,029
-97% -$4.76M ﹤0.01% 225
2023
Q1
$4.19M Sell
40,325
-8,909
-18% -$862K 0.11% 155
2022
Q4
$4.36M Sell
49,234
-3,069
-6% -$255K 0.11% 160
2022
Q3
$3.92M Buy
52,303
+24,793
+90% +$2.34M 0.1% 206
2022
Q2
$2.63M Sell
27,510
-88
-0.3% -$10.6K 0.06% 243
2022
Q1
$4.1M Sell
27,598
-9,754
-26% -$1.36M 0.08% 233
2021
Q4
$5.29M Sell
37,352
-2,052
-5% -$291K 0.1% 215
2021
Q3
$5.16M Sell
39,404
-5,832
-13% -$763K 0.1% 210
2021
Q2
$6.22M Sell
45,236
-2,953
-6% -$404K 0.12% 201
2021
Q1
$6.29M Buy
+48,189
New +$5.8M 0.13% 207

Other funds holding CNMD

NFJ Investment Group's CNMD Position: Q1 2025 in Review

NFJ Investment Group sold out of CONMED (CNMD) in Q1 2025, closing a stake of 76,785 shares — an estimated $5.26M sold.

NFJ Investment Group first reported a position in CNMD in Q1 2021 and held it in 14 quarters. The position peaked at $6.48M in Q1 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • NFJ Investment Group reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • NFJ Investment Group sold 76,785 CONMED shares in Q1 2025, an estimated $5.26M.
  • NFJ Investment Group first reported a position in CONMED in Q1 2021 and held it in 14 quarters.
  • NFJ Investment Group's CONMED position peaked at $6.48M in Q1 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on NFJ Investment Group's 13F filing for Q1 2025, filed 15 May 2025.